Details for 2014004427

Up to date per 03.04.2026

Actions

Title / Product Name

Zelldurchlässiger Peptidhemmer des JNK-Signaltransduktionsweges zur Verwendung in der Behandlung von Entzündungserkrankungen des Auges

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2014004427

EP Publication Number

2902035

E-Number

1010084

Language

PCT Number

Publication Date

05.08.2015 A

20.06.2018 B1

Registration Date

20.06.2018

AT Publication Date

15.07.2018

Application Date

14.10.2011

Registration Number

Priorities

14.10.2010

PCT/EP2010/006284

25.01.2011

PCT/EP2011/000307

IPC

A61K 38/00 20060101AFI20150518BHEP

Maximum Duration of Protection

14.10.2031

Owner

Xigen Inflammation Ltd.Arch. Makariou III 195 Neocleous House 3030 LimassolCY

Representative

Mag. Dr. P. N. Torggler, Dipl.Ing. Dr. St. Hofinger, Mag. Dr. M. Gangl, MMag. Dr. C. Maschler, Dipl.Ing (FH) Dr. B. Hechenleitner, Dipl-Phys.Dr. A. LercherWilhelm-Greil-Straße 166020 InnsbruckAT

Inventor

Combette, Jean-Marc515, route de Terret 74140 Saint CerguesFR

Deloche, Catherine22, Avenue William-Favre 1207 GenfCH

Abadie, Claire8 rue des Francs-Tireurs 74000 AnnecyFR